Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00610355 in moderate COPD
NCT00808288Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of PF-00610355 in chronic obstructive pulmonary disease (COPD), sponsored by Pfizer. Started Mar 2010; status: completed.
02
Drugs
PF-00610355
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00808288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808288.